Pérol Y
Rev Fr Transfus Immunohematol. 1984 Jun;27(3):295-300. doi: 10.1016/s0338-4535(84)80169-5.
Since more than fifteen years ago, the occurrence of Cytomegalovirus (CMV) infections in transfused patients has incriminated blood as a potential vehicle for CMV transmission, resulting in post-transfusion mononucleosis (PTM). Although only Diosi and al. (1969) reported viraemia in two of 35 asymptomatic blood donors, CMV was not recovered from any leukocyte specimen of numerous healthy blood bank donors, assayed by cocultivation of undisrupted buffy coat with a virus sensitive monolayer of human fibroblasts. Nevertheless numerous experimental studies have shown that CMV might persist in very low titer or in a latent state in mononuclear leukocytes in monocytes and macrophages and in lymphocytes. A better knowledge of the site an mechanisms of latency should help to control CMV transmission by fresh and bank blood or transfusion of viable leukocytes.
自十五年多以前起,输血患者中巨细胞病毒(CMV)感染的发生就已将血液认定为CMV传播的潜在载体,从而导致输血后单核细胞增多症(PTM)。尽管只有迪奥西等人(1969年)报告了35名无症状献血者中有两人出现病毒血症,但通过将未破坏的血沉棕黄层与对病毒敏感的人成纤维细胞单层进行共培养检测,在众多健康血库献血者的任何白细胞标本中均未检测到CMV。然而,大量实验研究表明,CMV可能以极低滴度或潜伏状态存在于单核细胞、巨噬细胞和淋巴细胞中的单核白细胞中。对潜伏位点和机制的更好了解应有助于控制通过新鲜血液、库存血液或输注活白细胞传播的CMV。